Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)
China flag China · Delayed Price · Currency is CNY
7.52
+0.24 (3.30%)
May 20, 2026, 1:24 PM CST

SHA:603567 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
54.1378.911,0531,4541,0011,551
Short-Term Investments
--15.3914.7459.4513.63
Trading Asset Securities
0.410.440.540.430.51-
Cash & Short-Term Investments
54.5379.351,0691,4691,0611,565
Cash Growth
-93.12%-92.58%-27.22%38.43%-32.17%1.68%
Accounts Receivable
2,4142,5703,1562,5253,0413,369
Other Receivables
665.52672.651,0851,955811.14796.85
Receivables
3,0803,2424,2424,4803,8524,166
Inventory
1,2931,3181,488720.891,006733.26
Prepaid Expenses
---19.7267.5856.75
Other Current Assets
610.9508.76394.08478.08394.31155.07
Total Current Assets
5,0385,1497,1937,1686,3816,676
Property, Plant & Equipment
1,3881,4191,4811,4261,4681,455
Long-Term Investments
1,2871,3111,2981,2661,2231,236
Goodwill
14.8214.8214.8214.8217.2218.5
Other Intangible Assets
1,0541,060980.37784.03764.29209.36
Long-Term Deferred Tax Assets
660.56615.24321.12302.6242.28159.23
Long-Term Deferred Charges
211.33214.85246.06223.03217.62167.05
Other Long-Term Assets
845.11851.51,1781,2821,3641,585
Total Assets
10,50010,63412,71312,46611,67811,506
Accounts Payable
363.28341.1278.16332.99806.25797
Accrued Expenses
56.3351.6650.8843.9235.7634.99
Short-Term Debt
1,5271,3111,296876.191,302600.76
Current Portion of Long-Term Debt
1,1091,754439.61972.691,1421,047
Current Portion of Leases
--4.553.812.463.23
Current Income Taxes Payable
134.73130.57114.16101.9190.1356.84
Current Unearned Revenue
84.85127.5655.336.4654.9712.98
Other Current Liabilities
363.79369.54281.61387.2323.34259.28
Total Current Liabilities
3,6394,0862,5202,7553,8672,812
Long-Term Debt
506471,5461,2984601,290
Long-Term Leases
5.346.27.970.149.963.53
Long-Term Unearned Revenue
132.68137.45150.11169.34181.88197.24
Long-Term Deferred Tax Liabilities
20.4820.8137.9126.025.911.37
Other Long-Term Liabilities
58.1158.11159.3176.5746.37150.42
Total Liabilities
4,3624,3554,4224,4254,5714,455
Common Stock
941941941.14941.96941.96941.96
Additional Paid-In Capital
2,3232,3232,3392,3442,3502,350
Retained Earnings
2,8433,0234,5314,2813,8343,749
Treasury Stock
-13.89-13.89-15.1-22.04-29.99-
Comprehensive Income & Other
8.297.784.993.933.22.75
Total Common Equity
6,1016,2817,8017,5487,0997,043
Minority Interest
37.27-1.74490.45492.277.948.27
Shareholders' Equity
6,1396,2798,2918,0417,1077,051
Total Liabilities & Equity
10,50010,63412,71312,46611,67811,506
Total Debt
3,1483,1183,2943,1512,9262,945
Net Cash (Debt)
-3,093-3,039-2,225-1,682-1,865-1,380
Net Cash Per Share
-3.29-3.23-2.37-1.79-1.98-1.60
Filing Date Shares Outstanding
941.65939.27941.09939.4939.4941.96
Total Common Shares Outstanding
941.65939.27941.09939.4939.4941.96
Working Capital
1,3991,0634,6734,4132,5153,864
Book Value Per Share
6.486.698.298.047.567.48
Tangible Book Value
5,0325,2066,8056,7506,3176,815
Tangible Book Value Per Share
5.345.547.237.186.727.23
Buildings
--1,4041,2281,2321,276
Machinery
--1,2701,1911,1391,118
Construction In Progress
--149.42284.29260.83137.33
Source: S&P Global Market Intelligence. Standard template. Financial Sources.